Attention www.globalkeysolutions.net is now www.keypedia.com, read the full press release here.
KeyPedia LogoKeyPedia Icon
  1. Home
  2. /
  3. Records
  4. /
  5. Warning Letter
  6. /
  7. Continental Medical Labs, Inc.
WARNING LETTER
•Continental Medical Labs, Inc.•February 8, 2013

Continental Medical Labs, Inc. – FDA Warning Letter, Feb 8, 2013

Record Details

An FDA inspection of Continental Medical Labs Inc. (Waterford, WI) on February 6-8, 2013, revealed that the firm's sterile and non-sterile convenience kits, classified as medical devices, were adulterated. The manufacturing, packing, storage, or installation methods did not conform to the Current Good Manufacturing Practice (CGMP) requirements of the Quality System Regulation (QSR), 21 CFR Part 820. The firm's March 1, 2013, response to the FDA 483 was deemed inadequate for several issues. Key violations included: 1) Failure to validate processes with a high degree of assurance, specifically regarding sterilization re-validation, expiration dating, and seal parameters (21 CFR 820.75(a)). The firm continues distributing sterile kits without fully validated processes. 2) Failure to establish and maintain procedures for environmental control (21 CFR 820.70(c)). 3) Failure to establish and maintain CAPA procedures (21 CFR 820.100(a)). 4) Failure to maintain complaint procedures that include evaluating for Medical Device Report (MDR) requirements (21 CFR 820.198(a)(3)). 5) Failure to establish and maintain procedures for controlling non-conforming product (21 CFR 820.90(a)). 6) Failure to conduct management reviews of the quality system (21 CFR 820.20(c)). The FDA requires prompt corrective actions, including a written response within 15 working days detailing specific steps, prevention plans, documentation, and a timetable for completion. Interim controls for distributing sterile kits are also requested. Failure to comply may result in regulatory actions such as seizure, injunction, civil money penalties, and impact on federal contracts, device approvals, and Certificates to Foreign Governments.

Company
Continental Medical Labs, Inc.
Inspection date
February 8, 2013
Product type
Devices
Office
Minneapolis District Office
People
  • Michael Dutcher (Acting Assistant Commissioner)
  • William Wagner
View Company Profile

ID · 52a46162-8d5d-45c2-ad28-0c0d0e18f92c

Violation Codes8
21 U.S.C. 321(h)21 U.S.C. 351(h)21 CFR 820.75(a)21 CFR 820.70(c)21 CFR 820.100(a)21 CFR 820.198(a)(3)21 CFR 820.90(a)21 CFR 820.20(c)

Full citation text and observation details available on the Dashboard.

Your cart

Your cart is empty.

Browse public document pages and click Buy this document. We'll ask for your email at checkout, no account needed up front.

Browse documents

Discuss this record with AI

KeyPedia

ChatGPT

Claude

Perplexity

Grok

Copilot

Document or profile

One record shows the event. A profile shows the pattern.

Buy this document for the source file and details behind this single event.

Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.

Explore Continental Medical Labs, Inc.
KeyPedia
Regulatory Data Transformed
Stay in the loop

KRA score changes, company updates and news. About monthly, unsubscribe anytime.

Contact
New York Office:
370 Jay Street 7th Floor
Brooklyn, NY 11201
Scranton Office:
Scranton Enterprise Center, Suite 217
201 Lackawanna Avenue
Scranton, PA, 18503
🇺🇸+1 917-789-5099
🇪🇺+48 532-447-507
info@keypedia.com
Quick Links
HomePlatform OverviewMedia
KeyPedia™ Lite
Browse HubDatabase DirectoryRecordsCompaniesOfficesPeopleCareersAbout UsFounding TeamMeet Our ExpertsPartners
Legal & Ethics
Privacy PolicyTerms of ServiceOur Values & MissionCode of Ethics & AI Policy
©2026 KeyPedia™ | Global Key Solutions Corp. All rights reserved.